Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Richmond, Virginia, June 11, 2025 (GLOBE NEWSWIRE) -- Electrical infrastructure partnership delivers innovative solution for AI’s power demands at a greenfield 400 MW data center campus in...
-
Kuntarahoitus OyjPörssitiedote10.6.2025 klo 10.00 Kuntarahoitus laskee liikkeeseen 100 miljoonan Englannin punnan lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee...
-
Municipality Finance PlcStock exchange release 10 June 2025 at 10:00 am (EEST) Municipality Finance issues a GBP 100 million tap under its MTN programme On 11 June 2025 Municipality Finance Plc...
-
Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the company to ensure a smooth transition Allschwil, Switzerland – June 10,...
-
Guidance confirmed for clinical milestones for MP0533 and MP0712 in H2 2025Cash reach now anticipated to extend into 2028 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., June 10, 2025 (GLOBE...
-
Kuntarahoitus OyjPörssitiedote9.6.2025 klo 10.00 Kuntarahoitus laskee liikkeeseen 1 miljardin euron vihreän viitelainan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee liikkeeseen 1...
-
Municipality Finance PlcStock exchange release 9 June 2025 at 10:00 am (EEST) Municipality Finance issues a EUR 1 billion green benchmark under its MTN programme Municipality Finance Plc issues a...
-
The decision paves the way for broader digital asset adoption in the UK London, 6 June 2025 – 21Shares, one of the world’s leading issuers of cryptocurrency exchange-traded products (ETPs) and the...
-
Ad hoc announcement pursuant to Art. 53 LR Bondholder meetings will take place on Wednesday, June 25, 2025, to vote on proposals to amend the terms of the two outstanding convertible bonds CB 2025...
-
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a...